Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
Genomics
74%
Programmed Cell Death
37%
Gene Expression
36%
Proteomics
30%
Phosphoinositide 3-Kinase
30%
Protein Microarray
30%
Carcinogenesis
29%
Kinase
29%
Phosphotransferase
29%
Tumor Progression
28%
MicroRNA
27%
Epidermal Growth Factor Receptor
25%
Cell Proliferation
24%
Messenger RNA
23%
Tumor Suppressor Protein
22%
Oncogene
21%
Genetics
21%
Promoter Region
20%
Protein Kinase B
20%
Protein Expression
19%
Gene Expression Profiling
19%
P53
18%
Overall Survival
17%
Estrogen Receptor
17%
Lysophosphatidic Acid
17%
Immunity
15%
Methylation
15%
extracellular signal regulated kinase
14%
DNA Damage Response
14%
RNA
14%
Epigenetics
14%
DNA Repair
14%
DNA Methylation
14%
Somatic Mutation
13%
Stem Cell
12%
Cell Death
12%
Mammalian Target of Rapamycin
12%
Cell Cycle
12%
Upregulation
12%
Gene Mutation
12%
Transcription Factor
12%
T Cell
12%
Cell Migration
12%
Drug Resistance
12%
Wild Type
12%
Poly ADP Ribose Polymerase
12%
Cell Growth
11%
Receptor Tyrosine Kinase
11%
Gene Signature
11%
BRCA1
11%
Isoform
11%
Transcription
11%
Small Interfering RNA
11%
Clinical Trial
10%
DNA Damage
10%
Fibroblast
10%
Downregulation
10%
Long Non-Coding RNA
10%
Immune Checkpoints
10%
N-Terminus
9%
Next Generation Sequencing
9%
Transcriptome
9%
Mesenchymal-Epithelial Transition
9%
Cell Survival
9%
Cancer Stem Cell
9%
Anticancer
9%
Mouse Model
9%
Autophagy
8%
Tumor Suppressor Gene
8%
Pan-cancer
8%
Catenin
8%
Phosphatase
8%
Synapsin I
8%
Gene Dosage
8%
STAT3
8%
Growth Factor
8%
Homologous Recombination
8%
Cell Invasion
8%
RNA Sequence
8%
Interleukin 2
8%
Tyrosine Phosphorylation
7%
Transcriptomics
7%
Integrin
7%
Mediator
7%
Germ Cell
7%
Cisplatin
7%
Genome Instability
7%
Non-Coding RNA
7%
Genotyping
7%
DNA Sequence
7%
KRAS
7%
Protein Kinase
7%
AMP-activated Protein Kinase
6%
Single-Nucleotide Polymorphism
6%
Metabolic Pathway
6%
Autotaxin
6%
Cell Cycle Progression
6%
Gene Expression Data
6%
AKT1
6%
Medicine and Dentistry
Neoplasm
86%
Ovarian Cancer
74%
Breast Cancer
53%
Malignant Neoplasm
51%
Cancer Cell
49%
Cancer
22%
Metastatic Carcinoma
22%
Krukenberg Tumor
21%
Phosphoinositide 3-Kinase
20%
Biological Marker
20%
Programmed Cell Death
19%
Diseases
19%
Tumor Progression
18%
In Vitro
16%
Carcinogenesis
16%
Targeted Therapy
14%
Tumor Cell
14%
Gene Expression
14%
Cell Line
14%
Uterine Cancer
14%
Cell Signaling Pathway
13%
Cancer Therapy
12%
Proteomics
12%
Protein Kinase B
12%
Hepatocellular Carcinoma
11%
Melanoma
11%
Overall Survival
10%
Cancer Growth
10%
The Cancer Genome Atlas
10%
Epidermal Growth Factor Receptor
10%
Recurrent Disease
10%
Protein Microarray
10%
Cell Proliferation
10%
Messenger RNA
9%
Lysophosphatidic Acid
9%
extracellular signal regulated kinase
9%
Xenograft
9%
Receptor
9%
Non Small Cell Lung Cancer
9%
Phosphotransferase
9%
Lung Cancer
8%
Protein P53
8%
microRNA
8%
Autophagy
8%
Next Generation Sequencing
8%
Triple Negative Breast Cancer
8%
Drug Resistance
8%
Promoter Region
8%
Glioblastoma
8%
Gene Expression Profiling
8%
Tumor Microenvironment
8%
Primary Tumor
7%
Estrogen Receptor
7%
Upregulation
7%
Oncogene
6%
Protein Expression
6%
T Cell
6%
Clinical Trial
6%
Growth Factor
6%
Ovarian Tumor
6%
Cancer Types
6%
Cell Migration
6%
Epithelial Cell
6%
Cell Growth
6%
Abdominal Cancer
6%
Small Interfering RNA
5%
Protein Tyrosine Kinase
5%
Cell Invasion
5%
Somatic Mutation
5%
Reactive Oxygen Species
5%
Gene Mutation
5%
Antineoplastic Activity
5%
Head and Neck Squamous Cell Carcinoma
5%
Stem Cell
5%
Ovarian Cancer Cell Line
5%
Mammalian Target of Rapamycin
5%
Combination Therapy
5%
Personalized Medicine
5%
Immunity
5%
DNA Repair
5%
Keyphrases
Tumor
44%
Ovarian Cancer
42%
Breast Cancer
35%
In Cancer
24%
Phosphoinositide 3-kinase (PI3K)
24%
Apoptosis
16%
Interleukin-2
15%
Ovarian Cancer Cells
15%
Phosphorylation
14%
Overexpression
13%
Metastasis
13%
Hepatocellular Carcinoma
13%
Tumor Cells
13%
Cancer Cells
13%
Breast Cancer Cells
12%
Reverse Phase Protein Array
12%
Cell Proliferation
12%
T Cells
12%
Cancer Genome Atlas
11%
Induced Apoptosis
11%
Overall Survival
11%
Poor Prognosis
11%
Oncogene
10%
Gene Signature
10%
MicroRNA
10%
Growth Factors
10%
Lysophosphatidic Acid
10%
Cancer Types
9%
Protein Kinase
9%
Gene Expression
9%
Non-small Cell Lung Cancer (NSCLC)
8%
Small Interfering RNA (siRNA)
8%
Human Cancer
8%
Tumor Growth
8%
Tumor Suppressor
8%
PARP Inhibitor (PARPi)
8%
Mammalian Target of Rapamycin (mTOR)
8%
Autophagy
7%
Targeted Therapy
7%
Jab1
7%
High-grade Serous Ovarian Cancer (HGSOC)
7%
Tyrosine Kinase
7%
Tumor Progression
7%
Epidermal Growth Factor Receptor
7%
Tumorigenesis
7%
PIK3CA
7%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
6%
Confidence Interval
6%
Epithelial Ovarian Cancer
6%
C-Jun N-terminal Kinase
6%
Tumor Microenvironment
6%
Glioblastoma
6%
Signaling Pathway
6%
Genetic Modification
6%
Melanoma
5%
Knockdown
5%
Non-coding RNA (ncRNA)
5%
Clinical Outcomes
5%
Cancer Therapy
5%
Human Epidermal Growth Factor Receptor 2 (HER2)
5%
Tumor Suppressor Gene
5%
Tyrosine Phosphorylation
5%
AKT Pathway
5%
DNA Damage Response
5%
Yes-associated Protein 1 (YAP1)
5%
Triple-negative Breast Cancer
5%
Paclitaxel
5%
Cell Growth
5%
Estrogen Receptor
5%
Therapeutic Target
5%
Primary Tumor
5%
Integrin
5%
Colorectal Cancer
5%
AKT1
5%
Rapamycin
5%
P27Kip1
5%
Lung Cancer
5%
Clinical Significance
5%
PIK3CA mutation
5%
Soluble interleukin-2 Receptor (sIL-2R)
5%
Molecular Characterization
5%
Putative Drug Targets
5%
MEK Inhibitor (MEKi)
5%
Next-generation Sequencing
5%
Ca2+
5%
Gonadotropin-releasing Hormone
5%
Protein Expression
5%
Catenin
5%
Phosphatidylinositol 3-kinase Pathway
5%